Related Experiment Videos
[The effect of ouabain on sinus node function and intracardiac conduction (author's transl)]
Zeitschrift Fur Kardiologie
|May 1, 1977
Summary
Ouabain (O) i.v. did not worsen bradycardia or atrioventricular (AV) block in patients with sick sinus syndrome or AV block. Phenytoin did not improve Ouabain
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Context:
- Sick sinus syndrome and atrioventricular (AV) block are common cardiac conditions.
- Ouabain (O) is a cardiac glycoside with inotropic and chronotropic effects.
- Understanding Ouabain's effects on sinus node function and AV conduction is crucial for patient management.
Purpose:
- To investigate the electrophysiological effects of intravenous Ouabain (0.5 mg) on sinus node function and intracardiac conduction.
- To assess the safety and efficacy of Ouabain in patients with sick sinus syndrome and/or AV block.
Summary:
- His bundle electrography and atrial stimulation were used to evaluate Ouabain's effects in 14 patients with varying degrees of sinus node and AV conduction abnormalities.
- Ouabain prolonged sinus node recovery time in most patients and increased the AH interval, indicating slowed AV conduction.
- While Ouabain did not worsen bradycardia or AV block, phenytoin showed no beneficial effect on Ouabain-induced changes.
Impact:
- Ouabain appears to be relatively safe for patients with sick sinus syndrome and changing AV block, with no observed increase in adverse events.
- Findings contribute to the understanding of Ouabain's cardiac electrophysiological profile in specific patient populations.
- Further research may explore optimal Ouabain dosing and its role in managing complex cardiac arrhythmias.